HEPA Filter for Pharmaceutical Cleanrooms:

If you run a GMP facility, your question is not “do we need a HEPA filter?” but “are our HEPA systems specified, tested, and documented in a way an FDA or EU inspector will accept?” The short answer: regulators expect demonstrable control of HEPA performance across design, qualification, integrity testing, and supplier management. This guide walks through the key requirements so your hepa air filter strategy stands up in Annex 1 and 21 CFR 211 inspections.

Table of Contents

Regulatory Framework for HEPA Filtration in Pharma

EU GMP Annex 1 (2023 Revision) HEPA Requirements

Annex 1 (2023) tightens expectations for cleanroom air handling:

Grade A/B must have unidirectional airflow with HEPA filtered air, normally H14 or better, supplying the critical zone.
All air supplied to Grade A/B, and generally C/D, should be HEPAfiltered, with design and qualification data available.
The document emphasizes a Contamination Control Strategy (CCS), where HEPA performance is a key element.

In our experience, EU inspectors now ask not only “where are the HEPA filters?” but also how HEPA integrity and performance are trended and linked to your CCS.

FDA 21 CFR Part 211 and Guidance for Industry

FDA 21 CFR 211 doesn’t use the word HEPA directly, but it does require:

42: “Adequate control over air pressure, micro-organisms, dust, humidity, and temperature.”
Aseptic processing guidance explicitly references HEPA-filtered unidirectional air for aseptic zones.

For US sites, FDA expects you to justify hepa filter filters selection and testing as part of the facility design and process validation package, even if not spelled out line-by-line in the CFR.

WHO Technical Report Series Guidelines

WHO TRS 961 / 1019 (Annexes on sterile products) echo EU GMP:

HEPA filtration for Grade A/B zones.
Regular filter integrity testing and documentation.

Many countries outside the US/EU base their GMP frameworks on WHO TRS, so if you align with Annex 1 and WHO, your air filter HEPA strategy will typically satisfy most regulators.

HEPA Filter Selection for GMP Grade Classifications

Grade A/B Zones: H14 or ULPA Requirements

For Grade A/B:

Most facilities specify H14(EN 1822) HEPA filters: ≥99.995% efficiency at MPPS.
Some advanced aseptic isolators and RABS may use ULPA (U15) in localized modules, but H14 at the room level is typically acceptable.

Key points:

Use terminal hepa air filtermodules with gel-seal and knife-edge frames for reliable sealing.
Ensure filters are individually tested and certified per EN 1822 / ISO 29463.

From the projects we’ve completed on sterile injectables, trying to justify H13 in Grade A/B is increasingly difficult unless there is a strong risk-based rationale and robust barrier technology.

Grade C/D Areas: H13 HEPA Specifications

For Grade C/D:

H13filters (≥99.95% at MPPS) are generally accepted for supply air.
Some clients still choose H14 in Grade C to align with corporate standards, but it is not universally mandated.

Typical approach:

H13 terminal filters in Grade C production and support areas.
H13 or high-efficiency prefiltration upstream for Grade D / ISO 8 corridors.

Correctly sizing these hepa filter filters helps keep fan energy reasonable while maintaining GMP expectations.

Filter Selection for CNC and Support Areas

Controlled-not-classified (CNC) and non-critical support areas:

Often use high-efficiency non-HEPA filters (e.g., ePM1 80% / F9) or H13 depending on process risk.
The CCS should define where full HEPA filtration is needed vs high-grade prefiltration.

In our experience, over-specifying HEPA everywhere in a plant can double filter and fan costs without measurable quality benefit—focus H14/H13 where they actually protect product.

Qualification and Validation Requirements

Factory Acceptance Testing (FAT) Protocols

Before shipment, FAT for HEPA systems should cover:

Visual and dimensional checks of housings and frames.
Verification of hepa filtercertificates (EN 1822 class, serial numbers).
Basic leak tests at the factory (type tests).

For large projects, we often help clients witness FAT at the filter or FFU manufacturer to verify labels, COAs, and packaging before thousands of filters leave the factory.

Site Acceptance Testing (SAT) Procedures

At site:

Confirm installation per design (location, orientation, sealing method).
Perform initial air volume/velocity checks and smoke studies where unidirectional flow is required.
Prepare for first integrity test before operational qualification.

SAT is your chance to catch damaged filters or mis-installed housings before you get deep into IQ/OQ.

Ongoing Monitoring and Requalification Schedules

For GMP facilities, typical practice:

Full HEPA integrity testing: every 12–24 monthsfor Grade A/B/C; sometimes longer for Grade D, per risk.
Airflow/velocity checks: at least annually, often tied to requalification events.
Environmental monitoring trends: used to support or adjust retest intervals.

In our experience, linking HEPA requalification to EM trends and deviation history makes your schedule defensible during audits.

Integrity Testing Methods per GMP Standards

Aerosol Photometer Testing (DOP/PAO Method)

The classic method:

Generate PAO or DOP aerosol upstream of the hepa filter.
Use a photometer to scan the downstream face and perimeter.
Acceptance criteria: usually max 0.01–0.03% penetration, depending on internal standards.

Method references:

ISO 14644-3:2019 Annexes.
IEST RP-CC034 and related recommended practices.

Particle Counter Scanning Technique

Where photometer testing is impractical:

Some sites use particle counter scanning at 0.3 μm or MPPS-sized particles.
Limits must be carefully set to approximate photometer sensitivity.

This approach can be more time-consuming but avoids oil-based aerosols in some sensitive environments.

Test Frequency Requirements and Documentation

Minimum expectations in GMP:

Documented test SOPs, acceptance criteria, and responsibilities.
Detailed test reports per filter bank: date, technician, instrument calibration, raw data, and conclusion.
Inclusion of HEPA integrity results in annual product reviews or quality management review.

Missing or weak documentation around integrity testing is a very common FDA 483/Annex 1 observation.

Supplier Qualification for GMP HEPA Filters

Quality System Requirements (ISO 9001, ISO 14001)

Your HEPA supplier should have:

ISO 9001 certification as a baseline.
ISO 14001 (environmental) and/or ISO 45001 (safety) are positive signs for larger partners.

For high-risk operations (e.g., cytotoxic drugs), some QA teams also assess:

Cleanliness and control of the supplier’s own production environment.
Their history with GMP or healthcare clients.

Traceability and Certificate of Analysis Documentation

At minimum, require:

Unique serial/lot numbers on each hepa air filter.
Individual EN 1822 / ISO 29463 test certificates with efficiency and leak data.
Material declarations (media type, frame, gasket) and operating limits.

In our experience, a tight traceability chain is invaluable when investigating any HEPA-related deviation or considering product impact.

Change Control Notification Agreements

Include in your supplier quality agreement:

Commitment to notify you before any change in:
- Media supplier or formulation.
- Frame design or gasket material.
- Manufacturing location or test method.

Uncontrolled supplier changes are a classic GMP risk—your QMS should treat significant HEPA design changes like any other critical raw material change.

Common GMP Audit Findings Related to HEPA Systems

Missing or Inadequate Integrity Test Records

Typical findings:

No proof of recent HEPA integrity tests in Grade A/B zones.
Incomplete data (e.g., only “pass/fail” noted, no raw values).

Mitigation:

Ensure every integrity test generates a signed report filed in the validation or maintenance system.
Cross-reference test IDs in EM and qualification summaries.

Improper Filter Change-Out Documentation

Problems auditors see:

No records of hepa replacement filterserial numbers or change dates.
No approval or QA review of filter change activities.

Good practice:

Log every change-out with filter ID, date, reason, and test results.
Treat HEPA filters like critical equipment components under change control.

Uncontrolled Supplier Changes

Common scenario:

Supplier quietly switches media or frame material to save cost.
Your EM trends drift or integrity failures rise.

From the projects we’ve completed, introducing formal supplier change notification requirements and periodic supplier audits reduced “mystery” performance shifts significantly.

Frequently Asked Questions

Does EU GMP Annex 1 mandate H14 for all Grade A areas?

Annex 1 does not spell out “H14” by name, but:

It expects HEPA filtration of Grade A/B with very low particle counts.
In practice, regulators and industry consensus treat H14as the norm for Grade A/B supplies, often extended to local unidirectional flow devices.

So while not line-by-line mandated, using H13 in Grade A without a strong justification is likely to invite questions.

How should HEPA filter failures be investigated under GMP?

Treat a failed integrity test as a deviation:

Quarantine affected areas or assess impact on product (via risk assessment).
Investigate root cause (media vs frame vs installation vs test error).
Replace or reseat the failed hepa filter, then retest.
Evaluate historical EM and batch records for potential product impact.
Document CAPA and update procedures if systemic issues are found.

Your investigation depth should match the zone risk (Grade A/B issues typically require more rigorous analysis).

What HEPA documentation is required for FDA pre-approval inspections?

FDA will typically expect:

Design documents showing HEPA locations, classes, and airflow patterns.
IQ/OQ/PQ reports including integrity test results and air change/velocity data.
Ongoing EM and HEPA requalification records demonstrating sustained control.
Supplier COAs and evidence of appropriate hepa filterselection and change control.

From the projects we’ve completed leading up to PAI/PAIs, having all HEPA-related documents in a single, indexed binder or digital folder significantly streamlines inspections.

Handled well, your hepa filter strategy becomes a strong pillar of your contamination control system rather than a recurring audit weakness. By selecting appropriate H13/H14 filters per grade, rigorously validating and integrity-testing them, and managing suppliers under formal change control, you turn HEPA filtration from a commodity component into a fully traceable, GMP-defensible control point in your pharmaceutical cleanroom.

We'll call you

In order to serve you better, if you could kindly send an e-mail to nick@biogreenness.com for questions and details about your theoretical and special architectural plans, projects, and product specifications, your request will be responded to as soon as possible.

We'll call you

In order to serve you better, if you could kindly send an e-mail to nick@biogreenness.com for questions and details.

HEPA Filters for Pharmaceutical Cleanrooms: GMP Compliance Guide

Regulatory Framework for HEPA Filtration in Pharma

EU GMP Annex 1 (2023 Revision) HEPA Requirements